Leap Therapeutics effecting 10-for-1 reverse stock split to regain Nasdaq compliance

CYPHERPUNK TECHNOLOGIES INC.

Reverse stock split ratio of 10-for-1, effective 5PM ET on June 20, 2023.
Common stock to trade on split-adjusted basis under "LPTX" on Nasdaq starting June 21, 2023.
Split approved by stockholders on June 16, 2023; board set final ratio.
Purpose: increase per-share price to meet Nasdaq minimum bid requirement and facilitate Series X preferred conversion.
No fractional shares issued; cash paid in lieu; all equity awards and warrants adjusted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.